BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 7488022)

  • 1. Only in the presence of immunophilins can cyclosporin and FK506 disrupt in vivo binding of calcineurin A to its autoinhibitory domain yet strengthen interaction between calcineurin A and B subunits.
    Chaudhuri B; Stephan C
    Biochem Biophys Res Commun; 1995 Oct; 215(2):781-90. PubMed ID: 7488022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between the catalytic A subunit of calcineurin and its autoinhibitory domain, in the yeast two-hybrid system, is disrupted by cyclosporin A and FK506.
    Chaudhuri B; Hämmerle M; Fürst P
    FEBS Lett; 1995 Jan; 357(2):221-6. PubMed ID: 7528690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes.
    Clipstone NA; Fiorentino DF; Crabtree GR
    J Biol Chem; 1994 Oct; 269(42):26431-7. PubMed ID: 7523407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiae.
    Parent SA; Nielsen JB; Morin N; Chrebet G; Ramadan N; Dahl AM; Hsu MJ; Bostian KA; Foor F
    J Gen Microbiol; 1993 Dec; 139(12):2973-84. PubMed ID: 7510323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin mutants render T lymphocytes resistant to cyclosporin A.
    Zhu D; Cardenas ME; Heitman J
    Mol Pharmacol; 1996 Sep; 50(3):506-11. PubMed ID: 8794888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A.
    Cardenas ME; Muir RS; Breuder T; Heitman J
    EMBO J; 1995 Jun; 14(12):2772-83. PubMed ID: 7540976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands.
    Cardenas ME; Hemenway C; Muir RS; Ye R; Fiorentino D; Heitman J
    EMBO J; 1994 Dec; 13(24):5944-57. PubMed ID: 7529175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of ternary immunophilin-calcineurin complexes with the immunosuppressants cyclosporin and macrolide FK506.
    Woerly G; Weber E; Ryffel B
    Biochem Pharmacol; 1994 Apr; 47(8):1435-43. PubMed ID: 7514409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The yeast FKS1 gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth.
    Eng WK; Faucette L; McLaughlin MM; Cafferkey R; Koltin Y; Morris RA; Young PR; Johnson RK; Livi GP
    Gene; 1994 Dec; 151(1-2):61-71. PubMed ID: 7530227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp).
    Wesselborg S; Fruman DA; Sagoo JK; Bierer BE; Burakoff SJ
    J Biol Chem; 1996 Jan; 271(3):1274-7. PubMed ID: 8576111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location.
    Bram RJ; Hung DT; Martin PK; Schreiber SL; Crabtree GR
    Mol Cell Biol; 1993 Aug; 13(8):4760-9. PubMed ID: 7687744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from alpha-factor arrest in yeast.
    Foor F; Parent SA; Morin N; Dahl AM; Ramadan N; Chrebet G; Bostian KA; Nielsen JB
    Nature; 1992 Dec; 360(6405):682-4. PubMed ID: 1281518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.
    Liu J; Farmer JD; Lane WS; Friedman J; Weissman I; Schreiber SL
    Cell; 1991 Aug; 66(4):807-15. PubMed ID: 1715244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity.
    Liu J; Albers MW; Wandless TJ; Luan S; Alberg DG; Belshaw PJ; Cohen P; MacKintosh C; Klee CB; Schreiber SL
    Biochemistry; 1992 Apr; 31(16):3896-901. PubMed ID: 1373650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of FKBP12-FK506 with calcineurin A at the B subunit-binding domain.
    Kawamura A; Su MS
    J Biol Chem; 1995 Jun; 270(26):15463-6. PubMed ID: 7541044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation.
    Milan D; Griffith J; Su M; Price ER; McKeon F
    Cell; 1994 Nov; 79(3):437-47. PubMed ID: 7525078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic NMR studies of ligand-receptor interactions: design and analysis of a rapidly exchanging complex of FKBP-12/FK506 with a 24 kDa calcineurin fragment.
    Fejzo J; Lepre CA; Peng JW; Su MS; Thomson JA; Moore JM
    Protein Sci; 1996 Sep; 5(9):1917-21. PubMed ID: 8880916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the immunophilin-immunosuppressant site of interaction on calcineurin.
    Husi H; Luyten MA; Zurini MG
    J Biol Chem; 1994 May; 269(19):14199-204. PubMed ID: 7514602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

  • 20. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.
    Kissinger CR; Parge HE; Knighton DR; Lewis CT; Pelletier LA; Tempczyk A; Kalish VJ; Tucker KD; Showalter RE; Moomaw EW
    Nature; 1995 Dec; 378(6557):641-4. PubMed ID: 8524402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.